institute of molecular immunology (imi)

Font size »A . A+ . A++ .

Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Molecular Immunology (IMI)

Picture

Wissenschaft wird von Menschen gemacht
(W. Heisenberg, Der Teil und das Ganze)

 

Institute of Molecular Immunology

The research activities of the Institute of Molecular Immunology focus on the boundary between hematology, immunology, oncology and transplantation biology. This is where concepts are developed for modulating the immune system by means of cell and molecular biological methods. New strategies are investigated for immunotherapy and gene therapy for cancer, autoimmune diseases and graft rejections.

Working groups

  1. Dendritic cell – T cell interactions
     Head: Prof. Dr. Dolores J. Schendel
     Principal investigator: Dr. rer. nat. Bernhard Frankenberger

  2. Antitumour immunity and adoptive T-cell therapy in renal cell carcinoma
    Head: PD Dr. rer. nat. Elfriede Nößner

  3. Regulation of innate and adaptive immunity as the basis for new approaches of immunotherapy
    Head: Prof. Dr.med. Ralph Mocikat

  4. Molecular programming of T-cell tolerance
    Head: Dr. rer .nat. Vigo Heissmeyer

  5. Core facility for generation of monoclonal antibodies and cell sorting
    Head: Dr. med. Elisabeth Kremmer
    Principal investigators: Dr. rer. biol. hum. Joachim W. Ellwart, Dr. rer. nat. Josef Mysliwietz

  6. GMP process development for cellular immunotherapies
     Head: Iris Bigalke
     
  7. Immune Monitoring Platform
    Head: Prof. Dr. Dolores J. Schendel
    Principal investigators: Prof. Dr. Ulrike Protzer, Prof. Dr. Dirk Busch

  8. Clinical Cooperation Group „Hyperthermia“
    Head: Prof. Dr. med. Rolf Issels

  9. Clinical Cooperation Group “Hematopoietic stem cell transplantation”
    Head: Prof. Dr. med. Hans-Jochem Kolb
    Kolb retired in April 2010 and KKG ended in Sept. 2010

  10. Platform for preclinical studies
    Head: Prof. Dr. med. Ralph Mocikat